313 related articles for article (PubMed ID: 9398039)
1. p16INK4, pRB, p53 and cyclin D1 expression and hypermethylation of CDKN2 gene in thymoma and thymic carcinoma.
Hirabayashi H; Fujii Y; Sakaguchi M; Tanaka H; Yoon HE; Komoto Y; Inoue M; Miyoshi S; Matsuda H
Int J Cancer; 1997 Nov; 73(5):639-44. PubMed ID: 9398039
[TBL] [Abstract][Full Text] [Related]
2. Expression of pRb and p16INK4 in human thymic epithelial tumors in relation to the presence of human polyomavirus 7.
Keijzers M; Rensspiess D; Pujari S; Abdul-Hamid MA; Hochstenbag M; Dingemans AM; Kurz AK; Haugg A; Maessen JG; De Baets MH; Zur Hausen A
Diagn Pathol; 2015 Nov; 10():201. PubMed ID: 26537237
[TBL] [Abstract][Full Text] [Related]
3. Expression and mutation statuses of epidermal growth factor receptor in thymic epithelial tumors.
Suzuki E; Sasaki H; Kawano O; Endo K; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
Jpn J Clin Oncol; 2006 Jun; 36(6):351-6. PubMed ID: 16762968
[TBL] [Abstract][Full Text] [Related]
4. Expression of apoptosis-related markers and HER-2/neu in thymic epithelial tumours.
Pan CC; Chen PC; Wang LS; Lee JY; Chiang H
Histopathology; 2003 Aug; 43(2):165-72. PubMed ID: 12877732
[TBL] [Abstract][Full Text] [Related]
5. p53 alterations in thymic epithelial tumours.
Weirich G; Schneider P; Fellbaum C; Brauch H; Nathrath W; Scholz M; Präuer H; Höfler H
Virchows Arch; 1997 Jul; 431(1):17-23. PubMed ID: 9247629
[TBL] [Abstract][Full Text] [Related]
6. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
[TBL] [Abstract][Full Text] [Related]
7. [Correlation between clinical aggressiveness of thymic epithelial tumors and expression of tumor suppressor gene products (p53, p27)].
Fukiwake N; Kase S; Yamazaki K; Yano T; Sugimachi K
Fukuoka Igaku Zasshi; 1999 Aug; 90(8):339-41. PubMed ID: 10496046
[TBL] [Abstract][Full Text] [Related]
8. Thymic carcinoma arising in thymoma is associated with alterations in immunohistochemical profile.
Kuo TT; Chan JK
Am J Surg Pathol; 1998 Dec; 22(12):1474-81. PubMed ID: 9850173
[TBL] [Abstract][Full Text] [Related]
9. Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression.
Gorgoulis VG; Zacharatos P; Kotsinas A; Liloglou T; Kyroudi A; Veslemes M; Rassidakis A; Halazonetis TD; Field JK; Kittas C
Am J Pathol; 1998 Dec; 153(6):1749-65. PubMed ID: 9846966
[TBL] [Abstract][Full Text] [Related]
10. p16/CDKN2 alterations and pRb expression in oesophageal squamous carcinoma.
Busatto G; Shiao YH; Parenti AR; Baffa R; Ruol A; Plebani M; Rugge M
Mol Pathol; 1998 Apr; 51(2):80-4. PubMed ID: 9713590
[TBL] [Abstract][Full Text] [Related]
11. p53 protein expression and p53 gene mutation in thymic epithelial tumors. An immunohistochemical and DNA sequencing study.
Tateyama H; Eimoto T; Tada T; Mizuno T; Inagaki H; Hata A; Sasaki M; Masaoka A
Am J Clin Pathol; 1995 Oct; 104(4):375-81. PubMed ID: 7572785
[TBL] [Abstract][Full Text] [Related]
12. Mutational status of EGFR and KIT in thymoma and thymic carcinoma.
Yoh K; Nishiwaki Y; Ishii G; Goto K; Kubota K; Ohmatsu H; Niho S; Nagai K; Saijo N
Lung Cancer; 2008 Dec; 62(3):316-20. PubMed ID: 18448188
[TBL] [Abstract][Full Text] [Related]
13. Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas.
Azechi H; Nishida N; Fukuda Y; Nishimura T; Minata M; Katsuma H; Kuno M; Ito T; Komeda T; Kita R; Takahashi R; Nakao K
Oncology; 2001; 60(4):346-54. PubMed ID: 11408803
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.
Caca K; Feisthammel J; Klee K; Tannapfel A; Witzigmann H; Wittekind C; Mössner J; Berr F
Int J Cancer; 2002 Feb; 97(4):481-8. PubMed ID: 11802210
[TBL] [Abstract][Full Text] [Related]
15. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
[TBL] [Abstract][Full Text] [Related]
16. Alterations of the p16/Rb/cyclin-D1 pathway in vulvar carcinoma, vulvar intraepithelial neoplasia, and lichen sclerosus.
Lerma E; Esteller M; Herman JG; Prat J
Hum Pathol; 2002 Nov; 33(11):1120-5. PubMed ID: 12454817
[TBL] [Abstract][Full Text] [Related]
17. Abnormal expression of cell cycle regulatory proteins in ductal and lobular carcinomas of the breast.
Geradts J; Ingram CD
Mod Pathol; 2000 Sep; 13(9):945-53. PubMed ID: 11007034
[TBL] [Abstract][Full Text] [Related]
18. Aberrant methylation of tumour-related genes in thymic epithelial tumours.
Hirose Y; Kondo K; Takizawa H; Nagao T; Nakagawa Y; Fujino H; Toba H; Kenzaki K; Sakiyama S; Tangoku A
Lung Cancer; 2009 May; 64(2):155-9. PubMed ID: 18778870
[TBL] [Abstract][Full Text] [Related]
19. Alterations of p16-pRb pathway and chromosome locus 9p21-22 in sporadic invasive breast carcinomas.
Gorgoulis VG; Koutroumbi EN; Kotsinas A; Zacharatos P; Markopoulos C; Giannikos L; Kyriakou V; Voulgaris Z; Gogas I; Kittas C
Mol Med; 1998 Dec; 4(12):807-22. PubMed ID: 9990866
[TBL] [Abstract][Full Text] [Related]
20. No p16INK4A/CDKN2/MTS1 mutations independent of p53 status in soft tissue sarcomas.
Meye A; Würl P; Hinze R; Berger D; Bache M; Schmidt H; Rath FW; Taubert H
J Pathol; 1998 Jan; 184(1):14-7. PubMed ID: 9582521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]